TCRX — TSCAN THERAPEUTICS INC

Ownership history in BVF INC/IL  ·  11 quarters on record

This page tracks every 13F SEC filing in which BVF INC/IL reported a position in TSCAN THERAPEUTICS INC (TCRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.65% (2024 Q1)
Avg. % of fund
0.35%
First filed
2023 Q2
Last filed
2025 Q4
Quarters held
11
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 5,226,074 — 0% 0.18% $5.2M $1.00
2025 Q3 UNCHANGED 5,226,074 — 0% 0.39% $9.5M $1.82
2025 Q2 ADDED 5,226,074 +336,600 +6.9% 0.27% $7.6M $1.45
2025 Q1 ADDED 4,889,474 +1,900,000 +63.6% 0.28% $6.7M $1.38
7 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    TCRX price (monthly, adj. close)

Other funds also holding TCRX

As of 2025 Q4 — sorted by position size

DC Funds, LP 3Y 43.36% Lynx1 Capital Management LP 3Y 1.62% Deer Management Co. LLC 3Y 0.12% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.02% BAKER BROS. ADVISORS LP 3Y 7Y 0.02% DC Investments Management, LLC 3Y 7Y 0.02% XTX Topco Ltd 3Y 0.01% Aberdeen Group plc 3Y 7Y 0.0% BRIDGEWAY CAPITAL MANAGEMENT, LLC 3Y 7Y 0.0% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 0.0%
← Back to BVF INC/IL Holdings